Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Wisconsin, Madison
Centre Leon Berard
Essen Biotech
University Medical Center Groningen
Children's Oncology Group
National Cancer Institute (NCI)
Hutchmed
University of Virginia
Bayer
Karolinska University Hospital
Bristol-Myers Squibb
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Novartis
SillaJen, Inc.
University of South Florida
Stanford University
Ann & Robert H Lurie Children's Hospital of Chicago